Department of Emergency Medicine Archive

July 22, 2020

Study to explore how COVID affects cognition over time

The Critical Illness, Brain Dysfunction and Survivorship Center at Vanderbilt University Medical Center is following patients who have been hospitalized for COVID-19 over time to see if they develop long-term cognitive impairment, depression or post-traumatic stress disorder (PTSD).

Ashley Brown Panas, MD, is one of several advanced providers on the Vanderbilt LifeFlight crew that include physicians and nurse practitioners.
July 22, 2020

LifeFlight adds NPs, physicians to expand flight crew

Patients treated and transported by Vanderbilt LifeFlight are now receiving a higher level of care thanks to the credentialing of more than 20 flight nurses as nurse practitioners and the addition of a flight physician at several LifeFlight bases.

Vanderbilt Wilson County Hospital’s (VWCH) Emergency Department transitioned to become part of Vanderbilt University Medical Center’s Department of Emergency Medicine.
July 16, 2020

Investments advance emergency medicine services at Vanderbilt Wilson County Hospital

On July 16, Vanderbilt Wilson County Hospital’s (VWCH) Emergency Department transitioned to become part of Vanderbilt University Medical Center’s Department of Emergency Medicine. The VWCH Emergency Department was previously staffed through physicians from a contracted agency.

July 16, 2020

Investigational glaucoma drug studied to prevent respiratory distress in COVID-19 patients

Vanderbilt University Medical Center is evaluating razuprotafib, a drug being investigated for the treatment of glaucoma, in a new randomized, investigational trial for the prevention and treatment of acute respiratory distress syndrome (ARDS) in adult patients with moderate to severe COVID-19.

July 9, 2020

About half of health care workers positive for COVID-19 by serology have no symptoms

The IVY Research Network has completed initial studies evaluating the epidemiology of COVID-19 in health care workers and patients.

June 21, 2020

Major U.S. trial closes showing no benefit for hydroxychloroquine in COVID-19

The Outcomes Related to COVID-19 Treated with Hydroxychloroquine among In-patients with Symptomatic Disease (ORCHID) trial stopped enrolling new patients based on the fourth scheduled interim analysis showing no evidence of benefit or harm.